Study Title: Phase Ib and Phase II Studies of Anti-PD-1 Antibody MK-3475 in Combination With Bevacizumab for the Treatment of Metastatic Renal Cell Carcinoma: Big Ten Cancer Research Consortium GU14-003
 

• Status: Completed

• Participating Sites:
  • University of Illinois Cancer Center
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Holden Comprehensive Cancer Center, University of Iowa
  • University of Michigan Rogel Cancer Center
  • Michigan State University Breslin Cancer Center
  • Masonic Cancer Center, University of Minnesota
  • Fred & Pamela Buffett Cancer Center (University of Nebraska)
  • Penn State Cancer Institute
  • Rutgers Cancer Institute of New Jersey
  • University of Wisconsin Carbone Cancer Center
• Learn more:
  • clinicaltrials.gov: NCT02348008
• Publications and Presentations:
  • Journal of Clinical Oncology: JCO.19.02394 (Published online, Feb. 25, 2020)
  • Poster Session: 2018 ASCO Annual Meeting
  • Poster Session: 2016 Genitourinary Cancers Symposium